Evidence mapPaperPMID 40722952Full record

ReviewAntioxidants (Basel, Switzerland)2025

Manganese Superoxide Dismutase: Structure, Function, and Implications in Human Disease.

Jovan Grujicic, Antiño R Allen

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Toxicity of the Covalent Organic Framework Material TpPa to Zebrafish.Animals : an open access journal from MDPI · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. The curious life of human mitochondrial SOD2.International journal of biological macromolecules · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jovan GrujicicDivision of Radiation Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.ORCID 0009-0009-8310-2945
Antiño R AllenDivision of Radiation Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.ORCID 0000-0002-4294-6473

Funding

NIH/NCI 1R01CA258673
6 · The paper itself

Abstract

Manganese superoxide dismutase (MnSOD) is a vital mitochondrial antioxidant enzyme that preserves cellular integrity by catalyzing the dismutation of superoxide radicals into hydrogen peroxide. Its central role in maintaining redox homeostasis has positioned it as a key target in biomedical research. This review provides an in-depth examination of MnSOD's structural and functional properties, regulatory mechanisms, and its involvement in the pathogenesis of various human diseases.

Indexed as

manganese superoxide dismutase (MnSOD)mitochondria-targeted antioxidantsoxidative stressreactive oxygen species (ROS)

Identifiers

PMID40722952
PMCPMC12291727

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.